1. Home
  2. KPRX vs IMG Comparison

KPRX vs IMG Comparison

Compare KPRX & IMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KPRX
  • IMG
  • Stock Information
  • Founded
  • KPRX 1998
  • IMG 2011
  • Country
  • KPRX United States
  • IMG Hong Kong
  • Employees
  • KPRX N/A
  • IMG N/A
  • Industry
  • KPRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • IMG
  • Sector
  • KPRX Health Care
  • IMG
  • Exchange
  • KPRX Nasdaq
  • IMG NYSE
  • Market Cap
  • KPRX 8.6M
  • IMG 10.3M
  • IPO Year
  • KPRX N/A
  • IMG 2020
  • Fundamental
  • Price
  • KPRX $2.99
  • IMG $0.26
  • Analyst Decision
  • KPRX Strong Buy
  • IMG
  • Analyst Count
  • KPRX 1
  • IMG 0
  • Target Price
  • KPRX $10.00
  • IMG N/A
  • AVG Volume (30 Days)
  • KPRX 62.4K
  • IMG 1.4M
  • Earning Date
  • KPRX 08-08-2025
  • IMG 08-18-2025
  • Dividend Yield
  • KPRX N/A
  • IMG N/A
  • EPS Growth
  • KPRX N/A
  • IMG N/A
  • EPS
  • KPRX N/A
  • IMG N/A
  • Revenue
  • KPRX $20,000.00
  • IMG $1,930,291.00
  • Revenue This Year
  • KPRX N/A
  • IMG $695.32
  • Revenue Next Year
  • KPRX N/A
  • IMG N/A
  • P/E Ratio
  • KPRX N/A
  • IMG N/A
  • Revenue Growth
  • KPRX N/A
  • IMG 9.80
  • 52 Week Low
  • KPRX $2.51
  • IMG $0.23
  • 52 Week High
  • KPRX $4.80
  • IMG $8.00
  • Technical
  • Relative Strength Index (RSI)
  • KPRX 47.28
  • IMG N/A
  • Support Level
  • KPRX $2.96
  • IMG N/A
  • Resistance Level
  • KPRX $3.29
  • IMG N/A
  • Average True Range (ATR)
  • KPRX 0.15
  • IMG 0.00
  • MACD
  • KPRX 0.01
  • IMG 0.00
  • Stochastic Oscillator
  • KPRX 38.78
  • IMG 0.00

About KPRX Kiora Pharmaceuticals Inc.

Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.

About IMG CIMG INC

CIMG Inc is a coffee and technologies company. The company is a co-packer of single-serve pour-over coffee, coffee brew bags and Dripkits. The company's brand portfolio includes Coffee Blenders, Twin Peaks, Active Cup, Relax Cup, Think Cup, Nude Cup, Pine Ranch Coffee, and Dripkit. Its geographical segments are North America, which accounts for the majority of revenue; and South Korea.

Share on Social Networks: